PAR4 inhibition as a novel therapeutic for multiple pathophysiologies

(1:31)

What is a PARP Inhibitor? | Dana-Farber Cancer Institute | Science Illustrated

(2:47)

How PARP inhibitors (PARPi) work

(3:12)

Toll-like Receptor-4 Inhibits Enterocyte Proliferation via Impaired...

(4:45)

Mechanisms of PARP Inhibition: A Mode of Targeted Cancer Treatment

(5:19)

What is a PARP Inhibitor?

(2:37)

Understanding and Overcoming PARP Inhibitor Resistance

(52:15)

PARP-inhibitors: A New Generation of Cancer Drugs

(3:12)

Understand the Adverse Events of PARP Inhibitors

(41)

Inhibition of TLR-4 attenuates systemic immune response in hermorrhagic shock

(6:8)

Exploring the Mechanism of CYP3A4 Inactivation by Lapatinib Through In Vitro Metabolite Char.

(56:54)

Active site of the coronavirus main protease with an inhibitor bound.

(23)

Case 4: PARP Inhibitors for Treating BRCA+ Triple-Negative Breast Cancer

(3:46)

The Gi Pathway Part 4

(5:53)

Earl W. Davie Symposium 2023 - Keynote Speaker: Dr. Paul F. Bray

(48:55)

Hypothalamic Circuits for Predation and Evasion

(4:52)

PARP Inhibitors and Platinum Sensitivity or Resistance

(4:31)

TALAVE: induction talazoparib with PARP inhibition in breast cancer

(2:47)

Unraveling the Mysteries of Platelet-Activating GPCR Signaling

(14:46)